✦ LIBER ✦

Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours

✍ Scribed by P.A. Ellis; A. Norman; A. Hill; M.E.R. O'Brien; M. Nicolson; T. Hickish; D. Cunningham

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin, cisplatin, and protracted in

✍ MyungAh Lee; InSook Woo; Jin-Hyoung Kang; YoungSeon Hong; KyungShik Lee 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 186 KB

575 Epirubicin (E), cisplatin (C) and co

✍ C. Underhill; M. Highley; P. Harper; J. Ahem; S. Barker; D. Miles; S. Houston; E 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Treatment of hepatocellular carcinoma (H

✍ Eveline Boucher; Stéphane Corbinais; Pierre Brissot; Karim Boudjema; Jean-Luc Ra 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 72 KB

Quality of life in patients with advance

✍ Sanambar Sadighi; Ali Mohammad Mohagheghi; Ali Montazeri; Zahra Sadighi 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 228 KB

Docetaxel and 5-FU continuous infusion (

✍ Thuss-Patience, P.; Kretzschmar, A.; Vielhaber, A.; Repp, M.; Junkers, R.; Tilin 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 195 KB

A prospective randomized phase III trial

✍ Kim, T.W.; Choi, S.J.; Ahn, J.H.; Bang, H.S.; Chang, H.M.; Kang, Y.K.; Lee, J.S. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB